throbber
Principles and Practice of·
`
`nco ogy
`
`Derek Raghavan, MBBS, PhD, FRACP, FACP
`Chief, Departments of Solid Tumor Oncology
`and Investigational Therapeutics
`Roswell Park Cancer Institute and
`Professor of Medicine and Urology
`State University of New York at Buffalo
`Buffalo, New York
`
`Howard I. Scher, MD
`Chief, Genitourinary Oncology Service
`Associate .Attending Physician
`Division of Solid Tumor Oncology
`Department of Medicine
`Memorial Sloan-Kettering Cancer Center
`New York, New York
`
`Steven A. Leibel, MD
`Vice Chairman and Clinical Director
`Attending Radiation Oncologist
`Department of Radiation Oncology
`Memorial Sloan-Kettering Cancer Center
`New York, New York
`
`Paul Lange, MD, FACS
`Professor and Chair .
`Department of Urology
`University of Washington
`Seattle, Washington
`
`With 226 Additional Contributors
`
`r Lippincott - Raven
`
`_ , P U B L
`
`I S H E R S
`
`Philadelphia • New York
`
`West-Ward Exhibit 1042
`True-Raghavan 1997
`Page 001
`
`

`

`- 1
`
`Developmental Editor: Eileen Wolfberg Jackson
`Project Editor: EUen M. Campbell
`Production Manager. C11TCn Erlichman
`Production Coordinator: MaryClare Malady
`Design Coordinator: Doug Smock
`Indexer. Steve Sorenson
`Compositor. Maryland Composition Company, Inc.
`Primer: Courier Book Company/Westford
`
`Copyright Cl I 997 by Lippincott-Raven Publishm. All rights reserved. This book is
`protected by copyright. No pan of it may be reproduced, stored in a retrieval system,
`or transmitted, in any form or by any means-electronic, mechanical, photocopy,
`recording, or otherwise-without the prior written peimission of the publisher, except
`for brief quotations embodied in critical articles and reviews. Printed in the United
`States of America. For information write Lippincott-Raven Publishers, 227 East
`Washington Square, Philadelphia, PA 19106-3780.
`
`Materials appearing in this book prepareed by individuals as part of their official duties
`as U.S. Gov~ent employees are not covered by the above-mentioned copyright.
`
`Library of Congress Cataloging-in-Publication Data
`Principles and practice of genitourinary oncology I Derek Raghavan ...
`[et al.] ; with 226 additional contributors.
`p. cm.
`Includes bibliographical references and index.
`ISBN 0-397-51458-1 (alk. paper)
`I. Raghavan, Derek.
`I. Genitourinary organs- Cancer.
`I. Urogenital Neoplasms. WJ 160 P9573 1996)
`(DNLM:
`RC280.U74P746 1996
`616.99'26-dc20
`DNLM/DLC
`for Library of Congress
`
`96-8893
`CIP
`
`Care has been taken to confirm the accuracy of the information presented and 10
`describe generally accepted practices. However, the authors, editors, and publisher are
`not responsible for errors or omissions or for any consequences from application of the
`information in ibis book and make no warranty, express or implied, with respect to the
`contents of the publication.
`The authors, editors, and publisher have exerted every effort t.o ensure that drug
`selection and dosage set forth in this text are in accordance with current
`recommendations and prac1ice at the time of publication. However, in view of ongoing
`research, changes in government regulations, and the constant flow of information
`relating to drug therapy and drug reactions, the reader is urged to check the package
`insert for each drug for any change in indications and dosage and for added warnings
`and precautions. Th.is is panicularly imponant when the recommended ageot is a new
`or infrequently employed drug.
`Some drugs and medical devices presented in this publication have Food and Drug
`Administration (FDA) clearance for limited use in restricted research settings. It is the
`responsibility of the health care provider to ascertain the FDA status of each drug or
`device planned for use in their clinical practice.
`
`9 8 7 6 5 4 3 2 I
`
`West-Ward Exhibit 1042
`True-Raghavan 1997
`Page 002
`
`

`

`Prindpl•s and Pracria of Genitourinary Oncology, edited by
`Derek Raghavan, Howard I. Scher, S1even A. Leibel. and Paul H.
`Lange. Lippincott-Raven Publishers. Philadelphia, 0 1997.
`
`CHAPTER 77
`
`Pathology of Renal Cancers
`
`Lavvrence D. True and David Grignon
`
`Although this chapter focuses on malignancies, benign tumors
`are discussed whe n relevant to the diffe rential pathologic diag(cid:173)
`nosis. Because an accurate pathologic diagnosis evolves from
`an accurate diffe remial diagnosis, charl s are provided thal list
`lhe differenti al d iagnostic considerations of lumors based on
`both gross and microscopic featu res. Furthennore, because :ic(cid:173)
`curale distinction of poorly differentiated tumors is best done
`by characterizing antigens expressed by the tumor cells, the
`immunohistochemical profiles of selected tumors is provided.
`lnfonnation is given concerning the genetic fea tures of renal
`cell carcinomas.
`
`EPITHELIAL NEOPLASMS
`
`Principles of Pathologic Classification
`
`The classification of renal epithelial tumors has traditionally
`been based on the cytologic and architectural patterns of growth.
`This approach is generally used in North America (see Table
`77-1 ). T hoenes and colleagues ' have proposed a system that is
`based on lhe cytoplasmic features of cells; this system has
`gained acceptance in Europe. Kovacs2 presented a scheme
`based on cytogenetic features. These sc hemes are summarized
`in Table 77-2.
`An assumption of these c lassifications is that cells in a given
`tumor have a common phenotype; however, many LUmors belie
`this assumption. Some renal cell carcinomas are composed of
`mixtures of clear cells, granular cells, and spindle cells, and
`mixed collecting duct-transitional cell carcinomas have been
`reported.3 The proporlion of cells of different histologic type
`comprising tumors may be prognostically important."
`
`Rena l Cell Carcinoma, Usual Type
`
`More than 90% of solid epithelial renal tumors are of the
`usual type. Although most cases occur sporadically, a small
`percentage of cases have a hereditary association (e.g., von Hip(cid:173)
`pel-Lindau disease, tuberous sclerosis, adult polycystic kidney
`disease). Hereditary tumors tend to fie mul tifocal and bilateral,
`in contrast with sporadic tumors, which tend to have a single
`
`focus and be unilateral. However, the histology of hereditary
`and sporadic tumors is identical. Both sporadic and familial
`tumors have simiJar cycogenetic changes, the most frequent of
`which are deletions within 3p. The von Hippel-Lindau locus
`has been mapped to 3p25. In add ition, most renaJ carcinomas
`have deletions within 3pl2-14.2.5- 9 Fluorescent in situ hybridi(cid:173)
`zation has demonstrated ploidy heterogeneity within tumors. 10
`Renal cell carcinomas have a highly variable gross appear(cid:173)
`ance. Typically, they are large, lobul ated masses !hat distort the
`kidney and bulge into perinephric fat (Fig. 77-1), which i.s not
`necessarily indicative of extracapsular invasion. A fibrous pseu(cid:173)
`docapsule gives these tumors a sharply circumscribed appear(cid:173)
`ance. The cut surface is variegated yellow (indicating eilher
`necrosis or the high lipid content of clear tumor cells or macro(cid:173)
`phages) Lo red-brown (indicating a granular cell component).
`Necrosis, hemorrhage, cystic change, and fibros is are frequent.
`Some cystic rumors resemble a multilocular cyst. Gross inva(cid:173)
`sion of the renal vein or vena cava occurs in as many as 40%
`of cases. 11
`Hiswlogically, the usual renal cell carcinoma is composed
`predominantly of clear, lipid-rich cells (Fig. 77-2). Variable
`numbers of eosinophilic (granular) and. rarely, spindle cells
`may be present. Tumors composed predominantly of spindle
`cells are classified as sarcomatoid carcinomas (discussed later).
`T he ratios of cell types may be of prognostic value4
`; an in(cid:173)
`creased proportion of s pindle cells portends a poorer prognosis.
`Typically, tumor cells grow as sheets or confl uent nests wid1
`a prominent sinusoidal vascular patte rn. Other pallems (e.g.,
`tubular, alveolar, papillary) may be present.
`The most common grading scheme is a four-point system
`based on nuclear features. 12 Grade I nuclei are small, round, and
`hyperchromatic, without observable nucleoli. Grade 2 nuclei a.re
`large, with an open chromatin pattern and s mall nucleoli. Grade
`3 nuclei have large, prominent nucleoli. Grade 4 nuclei are
`large and pleomorphic with marked atypia and hyperchromasia.
`Nuclear grade, which corre lates with mitotic activity, has signif(cid:173)
`icant prognostic power, independent of tumor stage. The grade
`assigned is that of the highest grade withi n the tumor, even if
`it is only focal. Nuclear inorphometry is potentially a more
`re liable way of grading renal carcinomas. 13
`Pathologic staging of resection specimens, using the TNM
`system of the Un ion lntemalionale Conire le Cancre, is based
`
`799
`
`West-Ward Exhibit 1042
`True-Raghavan 1997
`Page 003
`
`

`

`800
`
`I CHAPTER 77
`
`TABLE 77-1. Histologic classification of kidney tumors
`according to the modified WHO scheme
`
`TABLE 77-2. Classification schemes of renal epithelial
`j tumors
`
`Epithelial tumors of renal parenchyma
`Adenoma, including oncocytoma
`Carcinoma
`Usual renal cell carcinoma
`Other histologic types
`Epithelial tumors of renal pelvis
`Transitional cell papilloma
`Transitional cell carcinoma
`Squamous cell carcinoma
`Adenocarcinoma
`Undifferentiated carcinoma
`Nephroblastic tumors
`Nephroblastoma (Wilms' tumor)
`Mesoblastic nephroma
`Multilocular cystic nephroma (multilocular cyst)
`Nonepithelial tumors
`Benign
`Angiomyolipoma
`Fi bro ma
`Hemangioma
`Others, including leiomyoma, lipoma, and neurilem(cid:173)
`moma
`Malignant
`Sarcoma
`Miscellaneous tumors
`Juxtaglomerular cell tumor
`Others, including neuroblastoma, carcinoid, and teratoma
`Secondary (metastatic} tumors, including lymphoma
`Unclassified tumors
`Tumor-like lesions
`Renal blastema, persistent or massive
`Renal dysgenesis
`Cysts
`Xanthogranulomatous pyelonephritis
`Malakoplakia
`Others
`
`WHO
`(Mostofi, 1981}
`
`Thoenes et al,
`19861
`
`Adenoma
`Renal cell
`carcinoma
`Clear cell
`Granular cell
`Spindle cell
`Others
`Collecting duct
`Chromophobe cell
`
`Renal cell
`carcinoma
`Clear cell
`Chromophil
`Eosinophil
`Basophil
`Chromophobe
`Typical
`Eosinophil
`Collecting duct
`Oncocytoma
`
`Kovacs, 19932
`
`Papillary tumor
`Ade no ma
`Carcinoma
`Nonpapillary
`carcinoma
`Chromophobe
`carcinoma
`Oncocytoma
`
`on both gross and microscopic findings . Gross data include
`tum or size (the size threshold distinguishing TL and T 2 tumors
`is 2.5 cm in greate st dimension), invasion of perinephric tissues,
`involvement of extrarenal organs (e:g., lymph nodes, adrenal
`gland), and invasion of the renal vein, vena cava, or both. Micro(cid:173)
`scopic invasion of vessels is irrelevant for staging. Invasion of
`perinephric fat requires histologic confirmation that tumor cells
`extend beyond the kidney parenchyma and the tumor pseudo(cid:173)
`capsule, if present
`Stage is the best predictor of tumor behavior. 11 Mhrkers of
`cell proliferation, including mitotic activity, expression of pro(cid:173)
`liferating ce ll nuclear antigen or the Ki-67 epitope, and S-phase
`fraction of cells, determined by flow cytometry, correlate with
`grade and survival but do not consistently provide prognostic
`information of value beyond that provided by stage and
`grade. 14- 16
`
`Mostofi FK. Histological typing of kidney tumours. World
`Health Organization, Geneva, 1981.
`
`Adenoma
`
`The d is tinction between adenoma and carcinoma is an unre(cid:173)
`solved but significant issue, because many small lesions are
`
`FIG. 77-1 . The typical gross appearance
`of renal cell carcinoma is a large tumor
`mass with cystic areas admixed with
`bridging bands of fibrous tissue, and
`more solid areas of renal cell carcinoma,
`which are multifocally yellow as a result
`of the clear cell component of this tui:nor.
`
`West-Ward Exhibit 1042
`True-Raghavan 1997
`Page 004
`
`

`

`P AT HOLOGY O F RENAL C ANCERS
`
`I 801
`
`FIG. 77-2. The most common histologic
`pattern of clear cell-type renal cell carci(cid:173)
`noma consists of cells with a clear cyto(cid:173)
`plasm as a result of the high content of
`lipid, which is extracted during tissue pro(cid:173)
`cessing. Note the fine network of capillar(cid:173)
`ies between the nests of tu mor cells. This
`tumor is classified as Fuhrman's grade 2
`because of the small nuclei and infrequent
`nucleoli.
`
`being detected with increasingly sensitive techniques. ln a large
`autopsy series, small cortical epithelial lesions were found in
`2 1 % of patients; frequency increased with age, from 10% in 21-
`to 40-year-old patients to 40% in 70- to 90-year-old patients. 17
`Adenomas have other clinical associations. Those w ith a papil(cid:173)
`lary histology are often multiple and are associated with papil(cid:173)
`lary carcinoma. 18 Many patie nts with acquired cystic disease
`develop adenomas. Papillary adenomas have characteristic cy(cid:173)
`togenetic changes: trisomy 7 and 17 and loss of the Y chromo(cid:173)
`some. 18
`Grossly, the adenoma is sharply circumscribed and yellow(cid:173)
`tan to gray; it protrudes from the cortical surface. Histologically,
`the tumor has a tubulopapillary architecture and lacks a capsule,
`merging with adjacent renal parenchyma. Cells have an eosino(cid:173)
`philic to basophil ic cytoplasm and small, uniform nucle i (Fig.
`77-3). When clear tumor cells are present, the tumor should be
`regarded as a carcinoma, regardless of size.
`
`Investigators have used different pathologic criteria to distin(cid:173)
`guish adenoma from carcinoma. Size is not a sufficiently spe(cid:173)
`cific c riterion, because small tumors (as small as 0.5 cm in
`diameter) have metastasized. 19 Some authors restrict the diag(cid:173)
`nosis of adenoma to small lesions composed of closely packed
`tubules and papillae with small, uniform cuboidal cells hav ing
`nuclei of uniform size and shape and virtually absent mitoses.20
`Others recommend diagnosing such tumors as "small renaJ epi(cid:173)
`thelial neoplasms of low malignant potential. " 21 Adenoma
`should not be diagnosed by fi ne needle aspiration biopsy, be(cid:173)
`cause sampling may not be representative.
`
`Papillary Renal Cell Carcinoma
`
`As many as 10% of renal cell carcinomas are papillary var(cid:173)
`iants; according to Kovacs and Kovacs" 8 criteria, more than
`
`FIG. 77-3. A typical adenoma is not en(cid:173)
`capsulated and has a complex papillary tu(cid:173)
`bular architecture of cells with scanty baso(cid:173)
`philic cytoplasm and a high nuclear(cid:173)
`cytoplasmic ratio but minimal nuclear
`atypia. No mitoses are seen.
`
`West-Ward Exhibit 1042
`True-Raghavan 1997
`Page 005
`
`

`

`802
`
`I Ci V\PTER 77
`
`75% of the tumor must have a papillary architecture. The cells
`are typically chrnmophi lic (either eosinophilic or basophilic);
`clear cells are rare. Tumors that meet these patho logic c riteria
`have specific cytogenetic changes: trisomy or tetrasomy of 7
`and 17 and loss of the Y chromosome.2 Papillary adenomas
`have the same cytogenetic changes. No abnonnalities of 3p
`have been found in these lesions. In ~ddition, abnonnalities of
`chromosomes 12, 16, and 20 may be found and may mark the
`development of malignancy.2
`Grossly, papillary renal cell carcinoma is well circumscribed,
`brown, soft, and friable, with central cystic change. The cystic
`change is often no t a result of necrosis, which is uncommon.
`These wmors are often multifocaJ and are associated with small,
`papillary adenomas. The predominant histologic pattern is pap(cid:173)
`ilJary; small cuboidaJ or columnar cells of low cytologic grade
`line fibrovasc ular stalks which contain foamy hi stiocytes.
`Psammoma bodies may be present. Although these tumors have
`been associated with a better prognosis than the usual renal cell
`carc inoma, at least some of these tumors may behave aggres(cid:173)
`sively.22·23
`
`Oncocytoma
`
`Oncocytoma, ftrst reported in 1976, accounts for fewer than
`5% of solid renal tumors in adults.24 The most controversial
`aspect of this tumor concerns its malignant potential. The debate
`has been confused by the use of different pathologic crite(cid:173)
`ria.24-27 In studies using strict criteria, renal oncocytomas be(cid:173)
`haved in a unifonnJy benign nature. Cytogenetic studies also
`support distinguishing this tumor from the usual renal cell carci(cid:173)
`noma. The most frequent abnormality associated with oncocy(cid:173)
`toma is trisomy 17. Abnormalities in mitochondrial DNA have
`been found; 3p deletions are not presenr.28
`Grossly, the oncocytoma is a sharply c ircumscri bed, nonen(cid:173)
`capsulated tumor with a central stellate scar, wh ich may be
`inconspicuous in small tumors (Fig. 77-4). Oncocytomas are a
`uniform tan-brown or mahogany brown. Histologically, onco(cid:173)
`cytomas are composed of a pure population of round or cuboidal
`
`cells with coarse, granular, eosinophilic cytoplasm (Fig. 77-5).
`These cytoplasmic featurd are the result of abundant mitochon(cid:173)
`dria. An organoid growth pattern is typical, particularly in asso(cid:173)
`ciation with the scar. Solid, alveolar, or tubular patterns may be
`seen. Nuclei are round and of uniform size, with small, central
`nucleoli. Scallered cells with enlarged, atypical hyperchromatic
`nuclei are often present; this is considered a degenerative fea(cid:173)
`ture. Mitoses are not seen. According to some authors, the find(cid:173)
`ing of even a single mitosis excludes the diagnosis of oncocy(cid:173)
`toma. Extension into perinephric fat has been found in rare
`tumors th at had a benign clinical course.27
`Oncocytomas, by defin.ition, are not graded. T he possibility
`that a subset of oncocytomas with a high nuclear grade has
`mali gnant potential has been raised.26 However, the study on
`which this observation is based failed to apply strict criteria to
`dertning oncocyto'mas; the category "pink cell (or, granular,
`eosinophilic cell) tumors" of the kidney includes not only onco(cid:173)
`cytorna but also chromophobe cell carcinoma and eosinophilic
`papillary renal cell carcinoma.
`The minimal diagnostic criteria for oncocytoma include a
`characteristic gross appearance, a pure population of oncocytes,
`and the absence of mitoses. To satisfy these criteria, sampling
`should be thorough; at least one block of tissue per centimeter of
`maximum wmor dimension should be analyzed. The diagnosis
`should probably not be made either by frozen section or fi ne
`needle aspiration biopsy because of sampling limitation s.
`
`Cystic Renal Carcinoma
`
`Cysti c renal lesions have a variety of associations with renal
`cell carcinoma. Cystic degeneration is not uncommon in renal
`cell carc inoma; as many as 15% of renal cell carcinomas are
`radiographically cystic.29 Usually, the presence of cystic change
`presents a greater problem to the radiologist than to the patholo(cid:173)
`gist. However, in some cases, the identification of diagnostic
`tumor ti ssue may be problematic because of the paucity of
`tumor cells, which may be of low grade.
`Cystic renal carcinomas are characterized by variably sized,
`noncommuni cating cysts separated by irregular, thick, fibrous
`
`FIG. 77-4. The typical o ncocytoma is a
`round, circumscribed, tan-to-brown mass
`with a central stellate scar.
`
`J
`
`West-Ward Exhibit 1042
`True-Raghavan 1997
`Page 006
`
`

`

`PATHOLOGY OF RE-"IAL CANCERS
`
`I 803
`
`FIG . 77-5. Oncocytoma tumor cells form
`small nests in a fibrous, variably edema(cid:173)
`tous , myxoid stroma. The brown color of
`the gross tumor and the granular eosino(cid:173)
`philia seen mic roscopically result from the
`high content of mitochondria. Typical on(cid:173)
`cocytoma cells have large nuclei with
`prominent nucleoli.
`
`septae. The septae usually show marked hyalinization and may
`contain calcifications or foci of ossification. The tumor cells
`that line the cysts may be markedly attenuated or absent. Nests
`of tu mor cells can be fo und within the septae; tl1ese are most
`often of the c lear cell type. A uniloc ular variant has a thick
`irregular fibrous wall and a lining of tumor cells wh ich may be
`clear or granular. Characteristically, tl1ere are papillary cxcres(cid:173)
`censes; the papillae are covered by clear or granular cells.
`In cases resul ting fro m cystic necrosis of a previous ly solid
`rumor, the cyst contains hem orrhage and necrotic tissue. The
`cyst wall is thickened and irregular. These cases may be difficult
`to d iagnose because an epithelial lining is often absent. Any
`cystic mass in the kidney that contains hemorrhagic or.necrotic
`material s hould be suspected to be malignant and should be
`extens ively sampled.
`Carci nomas may arise in benign cystic disease of the kidney,
`including acquired cystic disease, adu lt polycystic kidney dis(cid:173)
`ease, and s imple unilocular cortical cysts.30•31 Tumors in simple
`cysts are typically small, solid, yellow nodules wiiliin U1e cyst
`wa ll. Histologically, most such tumors are composed of clear
`cells and have a low nuclear grade. The prognosis with these
`lesions is good.
`
`Collecting Duct (Bellini's Duct) Carcinoma
`
`Tl1is rare epithelial tumor, which was first recognized in
`1976, tends to occur at a younger age than the usual renal cell
`carcinoma.22·32·33 Many patients have a family history of can(cid:173)
`cer.33 Collecting duct rumors are located in the medulla, are
`gray-whi te, and show an infiltrative growth pattern. Necrosis
`is frequent. His to logically, collecting duct carcinomas typically
`have a m ixed papillary and infiltrati ve tubular arch itecture.
`There is pronounced stromal desmoplas ia. Often, tumor cells
`diffusely invade rena l parenchyma, trapping normal renal struc(cid:173)
`tures. Nuclear atypia is marked and mitoses are frequent. Dys(cid:173)
`plasia or carcinoma in situ may be found in the collecting ducts.
`Tumors have also been described in which this pattern is associ(cid:173)
`ated wi th a trans itional cell carcinoma.3 The common e mbryo] -
`
`ogic derivation of the collecting duct and renal pelvis is a histo(cid:173)
`gene tic basis for this event. A sarcomatoid variant has also been
`described.34 These tumors have a very aggress ive course. Of
`18 patients, 10 died o f metastatic disease within 2 years; the
`median survival was 22 months.33
`Recently, Davis and colleagues35 have reported as "renal
`mcdullary carcinoma" a highly mal.ignant tumor that occurs
`almost exclusively in individuals with sickle cell disease or trait
`and that shares ilie following pathologic features with collecting
`duct carcinoma: des moplastic stroma, marked nuclear atypia,
`in s itu neoplasia in the calyceal epithelium, and a medullary
`location. The authors consider it different, however, from col(cid:173)
`lecting duct carcinoma because of its distinctive histologic fea(cid:173)
`tures, including a reticular, yolk sac-like histology. General
`acceptance of renal medullary carcinoma as a new tumor type
`awaits confinnatory reports.
`
`Chromophobe Cell Carcinoma
`
`Chromophobe cell carci.noma, first reported in 1985, repre(cid:173)
`sents fewe r than 5% of renal cell carcinomas.36•37 This tumor
`warrants distinction from oilier variants because of its unique
`morphology and cytogenetic features and the possibility of mis(cid:173)
`diagnosing it as an oncocytorna. Many cases of "malignant
`oncocytoma" actually represent chromophobe cell carcinoma.
`Cy to genetically, there is loss of cilromosomes 1, 2, 6, 10, l 3,
`17, 2 1 and of sex chromosomes; no loss of 3p has been fo und.38
`Grossly, the tumor is circumscribed and tan to brown. Areas
`of necrosis and hemorrhage may be fou nd. No cenrral scar,
`which is characteristic of oncocytoma, is seen. Microscopically,
`there are two patterns. In the classic type, the cells are volumi(cid:173)
`nous, wiili a finely reticular, pale, eosinophilic cy toplasm,
`which tends to condense along the cell membrane, producing
`a perinuclear halo. The .eosinophilic type is characterized by
`smaller cells with a denser, finely granular, eosinophilic cyto(cid:173)
`plasm and a less conspicuous perinuclear halo.
`These rumor cells grow in a solid pattern with a capillary-rich
`stroma. Histochemical staining with Hale's colloidal iron shows
`
`West-Ward Exhibit 1042
`True-Raghavan 1997
`Page 007
`
`

`

`804
`
`I CHA PTER 77
`
`intense blue cytoplasmic reactivity; thi s result is no t seen in usual
`renal cell carcinoma or in oncocytoma. N uclei vary from small ,
`round , and hyperchromatic to large with clumped chromatin and
`prominent nucleoli. Ultrastructurally, the cells contain abundant
`microvesicles and variable numbers of mitochondria. The re(cid:173)
`ported cases of chromophobe cell carcinoma behaved in a man(cid:173)
`ner similar to that of usual renal cell carcinoma. 37
`
`Sarcomatoid Renal Cell Carcinoma
`
`As many as 5% of renal tumors in adults are sarcomatoid
`re nal cell carcinomas. A lthough their clinical presentation is
`similar to that of usual re nal cell carcinoma, sarcomatoid renal
`cell carcinomas often are of higher stage at diagnosis. 39Ao
`G rossly, this tumor is often a gray-white , infiltrating mass
`tha t is often contiguous w ith a usual renal ceU carc inoma. Histo(cid:173)
`logicaJly, sarcomatoid renal cell carcinoma is composed of ma(cid:173)
`lignant spindle ce lls that can mimic virtually any his tologic type
`of sarcoma.4 Tumor cells are often arranged as poorly formed,
`inte rlacing fascicles. Cytologically bizarre tumor cells and atyp(cid:173)
`ical mitoses are frequent. A lthough osteoid or chondroid mate(cid:173)
`rial may be present, a diagnosis of osteosarcoma or chondrosar(cid:173)
`coma s hould not be made. When no epithelial component can
`be found, evidence of epithelial differentiation should be sought
`by special studies (e.g., immunohistochemical localization of
`keratin to tumor cells, ultrastructural identification of desmo(cid:173)
`somes).41 Because sarcomatoid differentiation of carcinoma is
`more common than pure sarcoma of the kidney, malignant spin(cid:173)
`dle cell tumors of the kidney should be presumed to be carc ino(cid:173)
`mas until proven otherwise. Clinically, these tumors are highly
`maJ ignant. In one series, the 5-year survival rate was 19%.
`Adjuvant chemothe rapy may improve surv ivaJ.40
`
`Transitional Cell Carcinoma
`
`o r the kidney are similar .to that of transitional cell tumors in
`the urinary bladde r.42 Mosf transitional cell carcinomas are .low(cid:173)
`grade, noninvasive papillary neoplasms; invasive, high-grade
`tumors are less frequent. Rarely, these tumors have other histo(cid:173)
`logic components, including, in order of frequency, squamous,
`glandul ar, and sarcomatoid elements. Because of their low cyto(cid:173)
`logic grade and the diffic ulty of visuali zing and biopsying the
`re nal pelves and calyces, these tumors can be clinically and
`pathologically challenging to diagnose. As in the bladder, tumor
`s tage is of greatest prognostic power.43 Low grade and absence
`of aneuploid or tetraploid cell populations are indepe nde nt pre(cid:173)
`dictors of a good prognosis for low-stage tumors.44 For tumors
`that a but re nal parenchyma, distinguishing intraductal extension
`of tumor from renal parenchymal invasion probably is also of
`prognostic importance.45
`in frequently, re nal transitional cell carcinomas grow as solid
`masses that infiltrate the renal parenchyma and lack a papillary
`component (Fig. 77-6). The differential diagnosis of such a
`diffu se ly infiltrative tumor includes lymphoma and re nal cell
`carcinoma. Immunohistochemical characte rization of the tumor
`can help make the distinction. Transitional ce ll carcinomas are
`characterized by ex pression of high-molecular-weight keratins
`and o f keratin 20.46
`As in the urinary bladder, squamous cell carcinoma and ade(cid:173)
`nocarcinoma of the renal pelvis occur, although rarely. More
`often, squamous a nd glandular differentiation occur as compo(cid:173)
`nents of a transitional cell carcinoma. P ure sq uamous cell carci(cid:173)
`noma has distinctive clinical associations (i.e., renal calculi and
`a history of recurrent upper urinary tract infections). These tu(cid:173)
`mors have the same histology as their counterparts in the blad(cid:173)
`der. Patterns of adenocarci.noma of urothelium include papil(cid:173)
`lary, glandular, and muci.nous w ith signet ring formation.
`Differentiation from metastatic carcinoma can be diffic ult but
`can be aided by immunohistoc hemical studies. The prognosis
`associated with these tumors is poor.
`
`Neuroendocrine Neoplasms
`
`A pproximately 5 % of primary renal tumors are transitional
`cell carcinomas. These tumors originate in renal pelvic urothe l(cid:173)
`ium. The histology and biology of transitional cell carci nomas
`
`Primary ne uroendocri.ne tumors of the kidney are very rare.
`Fewer than one dozen cases of intrarenal neuroblastoma and
`
`FIG. n -6. Transitional cell carcinoma has
`only a minimal component in the collecting
`system. It diffusely infiltrates renal paren(cid:173)
`chyma as an irre_gular, white-to-tan mass.
`
`West-Ward Exhibit 1042
`True-Raghavan 1997
`Page 008
`
`

`

`48 Carcino id
`pheoc hromocytoma have been reponed in adu lts. 47
`•
`tumors of the kidney are sometimes hormonally active and have
`caused Cushing 's syndrome49 and hyperglucagonemi a.50
`Grossly, carcinoids are usually weU circumscribed, solid, and
`tan. Rarely, carcinoid is a component of cystic teratorna.5 1 Al(cid:173)
`though typically following a benign course, some carcinoids
`have had a lethal course.52
`.
`Small cell undifferentiated carcinoma of the kidney is whi te
`to tun, with an infiltrative margin. Histologically, this lesion is
`composed of sheets of tuinor cells that have scanty cytoplasm,
`a fine chromatin pattern, and inconspicuous nucleoli. Because
`the histology is identical with that of small cell carcinoma of
`other sites (e.g., lung), the possibility of the tumor being a me(cid:173)
`tastas is should be excluded clinically. Tbe association of small
`cell undifferentiated carcinoma of the kidney with tbe renal
`pe lvis53 and with concurrent transitional cell carcinoma of the
`pelvis54 raises the possibility that these tumors originate in tran(cid:173)
`sitional epithelium. Differentiation froni other diffusely infiltra(cid:173)
`tive, small cell undifferentiated tumors can be made by immu(cid:173)
`nohistochemistry. These tumors are highly malignant; most
`patients die of tumor within l year of diagnos is.55·56
`All of these neoplasms have a neuroendocrine phenotype.
`Neurosecretory granules can be found ultrastrucnirall y, and im(cid:173)
`munoreactive neuron-specific enolase, chromogranin, and syn(cid:173)
`aptophysin can be localized to tumor cells.
`
`Juxtaglomerular Cell Tumor (Reninoma)
`
`Patients with this rare tumor of juxtaglomerular cells, which
`are the nom1al site of renin synthesis, present clinically with
`severe hypertension as a result of abnormal renin secretion. The
`tumor can be difficult to localize when small; some of these
`lesions are smaller than 0.3 cm in size.57 The histology is varied,
`although localization of immunoreactive renin to tu01or cells
`and ultrastructural identification of distinctive rhomboidal crys(cid:173)
`tals confirm the diagnosis. Not all cases of hyperreni nemia(cid:173)
`associated hypertension are caused by renal reninomas; exam(cid:173)
`ples of renin-secreling renal carcinoma have been reported.58
`Reninomas are not malignant.
`
`P ATHOLOGYOF REN AL CANCERS
`
`I 805
`
`NONEPITHELIAL AND MUL TlLINEAGE
`NEOPLASMS
`
`Angiomyolipoma
`
`Angiomyolipoma is a benign hamartoma composed of vary(cid:173)
`ing ratios of smooth muscle, fat, and blood vesse ls. About 50%
`of angiomyolipomas occur in patients with tuberous sclerosis;
`conversely, between 50% and 80% of patients with tuberous
`sclerosis develop one or more angiomyolipomas. Most patients
`with multifocal angiomyol ipoma have tuberous sclerosis; how(cid:173)
`ever, in sporadic cases, the tumor is usually unilateral and uni(cid:173)
`focal .
`Grossly, the tumor is circumscribed and not encapsulated. It
`is usually variegated yellow '(because of adipocytes) and tan
`(because of smooth muscle cells). Areas of hemorrhage and,
`less frequently, necrosis can be seen.
`The classic angiomyolipoma is composed of three cell types:
`smooth muscle cells, which grow as sheets of generally eosino(cid:173)
`philic cells that do not form fascicles; adipose tissue; and thick(cid:173)
`walled, dysmorphic blood vessels (Fig. 77-7). An abundant adi(cid:173)
`pocyte component imparts a distinctive radiologic and gross
`appearance; however, in some cases the adipocyte component
`is sparse or even absent. The diagnosis of these angiomyolipo(cid:173)
`mas can be difficult, both radiologicaJ

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket